A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics

Completed · Phase 3

Conditions studied: Rhinitis, Allergic, Perennial

In brief

The purpose of this study is to assess the effect of an aqueous nasal spray investigational compound GW685698X compared to placebo on the hypothalamic pituitary adrenocortical (HPA) axis system in children 2 to 11 years of age with perennial allergic rhinitis.

Key facts

Study ID
NCT00116883
Run by
GlaxoSmithKline
People needed
90
Starts
2005-02-01
Expected to finish
2005-07-01
Last updated by the study team
2016-09-15

Who can join

Age: 2 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.